ABOUT US
pHion Therapeutics is a therapeutic vaccine development company, utilising its patented peptide based drug delivery system, RALA, which when combined with nucleic acids, generates a uniquely potent therapeutic response without provoking an innate immune response.
pHion’s therapeutic vaccine programme is focused on viral infections as it evokes a strong interferon gamma response. We believe that the RALA vaccine technology marks the advent of a new generation of therapeutic vaccines that could clear infectious diseases on a global scale.
In addition to therapeutic vaccines, RALA possesses unique traits that will offer significant value in both oncology (tumour specific delivery) and in ex vivo gene therapy (nanoparticle formulation for AAV manufacture) applications.
MEET THE TEAM
The pHion Therapeutics team includes inventors, scientists and legal staff from Queen's University Belfast and a wide variety of industry landscapes.
We believe that the individuals behind pHion Therapeutics represent the best minds investigating non-toxic cell penetrating peptides for drug delivery.
They stand ready to support the numerous and varied applications of RALA.
BOARD OF DIRECTORS
BOARD OF DIRECTORS
SCIENTIFIC ADVISORS